Commonwealth Equity Services, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022
SELL
$0.72 - $1.2 $36,866 - $61,443
-51,203 Closed
0 $0
Q4 2021

Jan 31, 2022
BUY
$1.0 - $1.82 $51,203 - $93,189
51,203 New
51,203 $51,000

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.4K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email